These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20939855)

  • 41. Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features.
    Galey KM; Wilshire CL; Niebisch S; Jones CE; Raymond DP; Litle VR; Watson TJ; Peters JH
    J Am Coll Surg; 2011 Jul; 213(1):155-61; discussion 162-3. PubMed ID: 21435920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premature lower esophageal sphincter closure as a cause of dysphagia.
    Allen ML; DiMarino AJ; Robinson M
    Am J Gastroenterol; 1993 Sep; 88(9):1377-80. PubMed ID: 8362834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases?
    Marjoux S; Brochard C; Roman S; Gincul R; Pagenault M; Ponchon T; Ropert A; Mion F
    Dis Esophagus; 2015; 28(8):735-41. PubMed ID: 25212219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A high-resolution view of achalasia.
    Jee SR; Pimentel M; Soffer E; Conklin JL
    J Clin Gastroenterol; 2009 Aug; 43(7):644-51. PubMed ID: 19077727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Achalasia, diffuse esophageal spasm, and related motility disorders.
    Vantrappen G; Janssens J; Hellemans J; Coremans G
    Gastroenterology; 1979 Mar; 76(3):450-7. PubMed ID: 428703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of gastroesophageal acid reflux and esophageal acid clearance in heartburn patients.
    Allen ML; Castell JA; DiMarino AJ
    Am J Gastroenterol; 1996 Sep; 91(9):1739-44. PubMed ID: 8792691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage.
    Krause E; Schirra J; Gürkov R
    Dysphagia; 2008 Dec; 23(4):406-10. PubMed ID: 18437465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lower esophageal sphincter dysfunction in diffuse esophageal spasm.
    Campo S; Traube M
    Am J Gastroenterol; 1989 Aug; 84(8):928-32. PubMed ID: 2756985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of the esophago-UES relaxation response: a possible pathophysiological mechanism in suspected reflux laryngitis.
    Szczesniak MM; Williams RB; Brake HM; Maclean JC; Cole IE; Cook IJ
    Neurogastroenterol Motil; 2010 Apr; 22(4):381-6, e89. PubMed ID: 20377793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
    Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
    Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Achalasia cardia with esophageal varix managed with endoscopic ultrasound-guided botulinum toxin injection.
    Lakhtakia S; Monga A; Gupta R; Kalpala R; Pratap N; Wee E; Arjunan S; Reddy DN
    Indian J Gastroenterol; 2011 Dec; 30(6):277-9. PubMed ID: 22180005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up of achalasic patients treated with botulinum toxin.
    D'Onofrio V; Annese V; Miletto P; Leandro G; Marasco A; Sodano P; Iaquinto G
    Dis Esophagus; 2000; 13(2):96-101; discussion 102-3. PubMed ID: 14601898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of achalasia with botulinum toxin.
    López P; Castiella A; Montalvo I; Bujanda L; Alzate LF; Gil I; Arenas JI
    Rev Esp Enferm Dig; 1997 May; 89(5):367-74. PubMed ID: 9190142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in esophageal and lower esophageal sphincter motility with healthy aging.
    Besanko LK; Burgstad CM; Cock C; Heddle R; Fraser A; Fraser RJ
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):243-8. PubMed ID: 25267950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Applications of botulin].
    Lindberg L; Kanerva M; Pitkäranta A; Ansaranta M; Ylitalo L; Aaltonen LM; Pakarinen M; Salmenkylä S
    Duodecim; 2011; 127(22):2431-43. PubMed ID: 22238921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing lower esophageal sphincter relaxation after deglutition.
    Tibbling L; Gezelius P; Franzén T
    World J Gastroenterol; 2011 Jun; 17(23):2844-7. PubMed ID: 21734792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas' disease.
    Meneghelli UG; Peria FM; Darezzo FM; Almeida FH; Rodrigues CM; Aprile LR; Dantas RO
    Dysphagia; 2005; 20(1):40-5. PubMed ID: 15886966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Achalasia: physiology and etiopathogenesis.
    Kraichely RE; Farrugia G
    Dis Esophagus; 2006; 19(4):213-23. PubMed ID: 16866850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subtle lower esophageal sphincter relaxation abnormalities in patients with unexplained esophageal dysphagia.
    Herregods TVK; van Hoeij FB; Bredenoord AJ; Smout AJPM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method.
    Schneider I; Thumfart WF; Pototschnig C; Eckel HE
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):31-5. PubMed ID: 8291857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.